Soltis Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
13,449
+1,870
+16% +$164K 0.07% 211
2026
Q1
$987K Buy
11,579
+552
+5% +$49.2K 0.06% 223
2025
Q4
$871K Buy
11,027
+373
+4% +$29.2K 0.06% 228
2025
Q3
$852K Sell
10,654
-370
-3% -$31.6K 0.06% 222
2025
Q2
$1M Buy
11,024
+546
+5% +$49.8K 0.08% 172
2025
Q1
$982K Sell
10,478
-267
-2% -$23.9K 0.09% 171
2024
Q4
$977K Buy
10,745
+8,480
+374% +$809K 0.09% 165
2024
Q3
$235K Buy
+2,265
New +$231K 0.02% 323

Other funds holding CL

Soltis Investment Advisors's CL Position: Q2 2026 in Review

Soltis Investment Advisors increased its Colgate-Palmolive (CL) stake by 16% in Q2 2026, buying an estimated $164K and bringing the position to 13,449 shares worth $1.23M. The position accounts for 0.07% of the portfolio, ranked #211.

Soltis Investment Advisors first reported a position in CL in Q3 2024 and has held it in 8 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Soltis Investment Advisors held 13,449 shares of Colgate-Palmolive worth $1.23M as of Q2 2026.
  • Soltis Investment Advisors bought 1,870 Colgate-Palmolive shares in Q2 2026, an estimated $164K.
  • Colgate-Palmolive made up 0.07% of Soltis Investment Advisors's portfolio in Q2 2026, its #211 holding.
  • Soltis Investment Advisors first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 8 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.